Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Funding Round

OSLO, Norway--(BUSINESS WIRE)--Norway Oncoinvent AS, a medical stage firm advancing a pipeline of radiopharmaceutical merchandise throughout quite a lot of stable cancers, introduced immediately that the corporate has raised NOK 250 million in an oversubscribed pre-IPO financing spherical syndicated by...

Oncoinvent Secures NOK 250 M in an oversubscribed Pre-IPO Funding Round | Business

OSLO, Norway--(BUSINESS WIRE)--Jun 29, 2021--Norway Oncoinvent AS, a scientific stage firm advancing a pipeline of radiopharmaceutical merchandise throughout a wide range of stable cancers, introduced immediately that the corporate has raised NOK 250 million in an oversubscribed pre-IPO financing spherical...